Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Topical tacrolimus is safe and effective for skin conditions, but oral tacrolimus has serious side effects.

Switching to generic tacrolimus was safe, effective, and saved money.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The model and estimator can predict drug exposure in kidney transplant patients well.